Known as the Wayne B. Duddlesten Free Enterprise Institute, the new program will operate in association with the UH Bauer College’s Cyvia and Melvyn Wolff Center for Entrepreneurship and be open to all UH students. Photo via bauerticker.uh.edu

A $5 million gift from the Wayne Duddlesten Foundation will establish expanded opportunities for entrepreneurship at the University of Houston, according to an announcement from the college earlier this month.

Known as the Wayne B. Duddlesten Free Enterprise Institute, the new program will operate in association with the UH Bauer College’s Cyvia and Melvyn Wolff Center for Entrepreneurship and be open to all UH students. It's expected to launch in 2024.

UH staff from the Duddlesten Institute and the Wolff Center will be able match budding entrepreneurs across campus with mentors, offer website-building resources, provide legal services and other tools.

"Our goal is to empower imaginative thinkers from idea to market," Paul A. Pavlou, dean of the Bauer College of Business and Cullen Distinguished Chair Professor, said in a statement. "We will support the process from a concept to incubation and continue offering necessary resources all the way to launching a successful new business.”

Dave Cook, executive director of the Wolff Center, said the new institute will create a new type of "synergy across campus."

"It will help create a fabric of innovation, talent, financial, legal and technical service along with a commitment to long held values of the importance of character and integrity as businesses are created," Cook said. "We are honored to share this vision through this collaboration.”

Duddlesten has been a longtime supporter of the university. The successful real estate developer, who's credited for bringing the Rockets to Houston in the '70s, was a Houston native and UH graduate.

His foundation donated $5 million to establish an endowed scholarship at Bauer for students studying entrepreneurship or real estate in 2020. It also established an endowed Tier One Scholarship and endowed scholarship in the Graduate College of Social Work, as well as 25 one-time scholarships for Wolff Center students over the years.

Duddlesten also served as a trustee emeritus and advisory board member for the UH Foundation and the UH System Development Board before his death in 2010.


Earlier this academic year, Rice University also unveiled a new facility dedicated to Ralph O'Connor, former president and CEO of the Highland Oil Company and founder of Ralph S. O’Connor & Associates. The $152 million, state-of-the-art facility features five floors of labs, classrooms and seminar rooms, and is Rice's largest core campus research facility. Click here to read more.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.